Russell Greig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Rockefeller universityNew yorkUnited statesBaden wübergUnited kingdomUniversity of pennsylvaniaCity ofUseh jack bissettSonia quaratinoPureos bioventuresBristol myers squibbIain kiltyJohn davisGerda blobelRussell greigJim hughes

Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board

Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomNucleome therapeuticsdr danuta jeziorskaRussell greigVifor pharmaDanuta jeziorskaCorporate executive teamUniversity of manchester united kingdomUniversity of oregon united statesInternational pharmaceuticals divisionUniversity of oxfordUniversity of british colombia canadaCorporate venture groupNucleome therapeuticsNon executive chairVenture groupUnited states

Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins Etherna as independent board member

/PRNewswire/ Etherna ("the Company"), a leading mRNA technologies company, announced today that Antonin (Tony) de Fougerolles has joined its board of.

Russell greigNovalis lifesciencesBernard sagaertResearch at alnylamHarvard universityEtherna the companyEvox therapeuticsChief scientific officerModerna therapeutics

Cardior Pharmaceuticals: Cardior Welcomes Dr Orly Vardeny as Permanent Guest to the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins

United statesRussell greigClaudia ulbrichKostenloser wertpapierhandelEva mulderClaudia ulbrich evaUniversity of minnesota medical schoolUniversity of minnesotaCardior pharmaceuticals gmbTrophic communicationsCardior pharmaceuticalsOrly vardenyMinnesota medical schoolAssociate editorHeart failureAmerican college

Cardior Appoints Axel-Sven Malkomes as Chief Financial Officer

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes

Kellogg schoolUnited statesHong kongUnited kingdomRussell greigClaudia ulbrichDonaldson lufkin jenretteKostenloser wertpapierhandelEva mulderAxel sven malkomesClaudia ulbrich evaUniversity of science technology in hong kongCredit suisseTrophic communicationsDeutsche bankLehman brothers